chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe low back & knee pain on my left side started 03/02/2021 approx 1:45 p.m. I took my usually prescribed pain meds at prescribed time 6:30 p.m., Oxycodone-Acetaminophen 10-325 & Tizanidine 2 mg, wrapped my left knee in ice & laid on a heating pad for 20 minutes, waited 20 minutes then iced my back. Pain not relieved & worse upon awakening on 03/03/2021 making it difficult to sit up & rise from bed. I took my prescribed meds & had difficulty performing morning ritual activities. I picked up a back brace on the way to work at 9:30 a.m. My ability to get into & out of my car was impaired. Pain not relieved & I was unable to lift usual items at work. Came home approximately 2:24 p.m., called my primary care physician's office to report pain situation & was told to call back 24 hrs if pain had not subsided.
Office Visit 3/16/2021    Family Medicine Viral URI +1 more Dx Cough  ? Nasal Congestion ? Facial Pain Reason for Visit Progress Notes (Physician) ? ? Family Medicine ? ? Encounter Date: 3/16/2021 ? ? Signed Expand AllCollapse All    Current Medications Current Outpatient Medications Medication Sig Dispense Refill ? aspirin (ASPIR-81) 81 mg tablet Take 81 mg by mouth daily  TO STOP 7 DAYS BEFORE SURGERY     ? atorvastatin (LIPITOR) 80 mg tablet TAKE 1 TABLET BY MOUTH EVERY DAY 90 tablet 3 ? celecoxib (CeleBREX) 100 mg capsule Take 100 mg by mouth 2 (two) times a day     ? cholestyramine (QUESTRAN) 4 gram packet Take 1 packet by mouth daily     ? dilTIAZem (CARDIZEM) 120 mg tablet Take 120 mg by mouth daily       ? DULoxetine (CYMBALTA) 30 mg capsule Take 30 mg by mouth nightly       ? esomeprazole (NexIUM) 40 mg capsule Take 40 mg by mouth daily       ? fluticasone propionate (FLONASE ALLERGY RELIEF) 50 mcg/actuation nasal spray Administer 2 sprays into affected nostril(s) once daily     ? furosemide (LASIX) 20 mg tablet Take 20 mg by mouth daily     ? gabapentin (NEURONTIN) 300 mg capsule Take 300 mg by mouth 2 (two) times a day       ? hydrALAZINE (APRESOLINE) 25 mg tablet Take 25 mg by mouth 2 (two) times a day       ? metoprolol succinate XL (TOPROL XL) 25 mg 24 hr tablet Take 25 mg by mouth nightly       ? miscellaneous medical supply (BARD CUNNINGHAM INCONTIN CLAMP) misc Apply to penis 2 each 3 ? multivitamin-minerals (PRESERVISION AREDS) 7,160-113-100 unit-mg-unit tablet Take 1 tablet by mouth 2 (two) times a day     ? nystatin-triamcinolone (MYCOLOG II) ointment Apply topically 2 (two) times a day  Apply twice to affected area x 2 weeks 15 g 3 ? OZEMPIC 1 mg/dose (2 mg/1.5 mL) subQ pen injector Inject 0.5 mg under the skin once a week  TAKES ON SUNDAY     ? ramipriL (ALTACE) 10 mg capsule Take 10 mg by mouth once daily       ? SITagliptan (JANUVIA) 50 mg tablet Take 50 mg by mouth daily     ? ULTICARE PEN NEEDLE 31 gauge x 1/4" needle USE 1 WEEKLY        No current facility-administered medications for this visit.
Information has been received from a physician concerning a female patient who reported her friend who on an unspecified date was vaccinated at another physicians office with a dose of GARDASIL (lot #unknown, site and route not reported). There was no concomitant medication. The patient had reported that her friend had "experienced lightheadedness while" driving 2.5 hours after receiving the vaccination. No additional information was reported. The patient's outcome was not reported. No further information is expected.
Patient had reaction after second dose of Pfizer- hives, pruritus, facial swelling, and swelling of the lips. Benadryl given and Epi given by EMS. Transported to ED and given Decadron in ED. Monitored for several hours and D/C'ed under stable condition.
Approximately 3 hours after shot I became nauseous, intestinal cramps with diarrhea.  Approximately 1 day later began having breathing issues.  Not like an asthma attack.  Just could not catch my breath, coughing trying to get air. I could not speak on the phone or in person without coughing to get air in my lungs.  I started using an inhaler but it was not helping.  I began using a Nebulizer; this helped slightly at first.  On Feb 20th (I got a new box of meds for the nebulizer) since then I have gotten another box of nebulizer meds on March 3rd.  I have used half of this box now.  Also, on March 3rd, my doctor called in for a new inhaler, which started with 200 sprays and as of today I have 15 left.  This has been going on for over a month!  I have been using the nebulizer every morning and at night but still would wake up 4-5 times during the night to use my inhaler.  I have difficulty feeding my horse without almost collapsing from lack of air.
Swelling then bruising at the site of PPSV23 injection. Swelling/Bruise extended from injection site to the medial border of the arm. Associated with myalgias.
Assessment and Plan Patient is a 52 y.o. female patient of PA-C with history of OSA, Chronic hypoxic respiratory failure, OCP, T2DM, HTN, HLD, Depression, fibromyalgia  presented to Hospital with  SOB. Patient left AMA on hospital day 1 shortly after the below note was completed.   Acute on chronic hypoxic respiratory failure COVID19 pneumonia Hx of Cryptogenic organizing pneumonia  OSA, non complaint to CPAP 2 weeks duration of cough with yellowish sputum, myalgia Received J&J COVID vaccine (single dose), no boosters Only on 2L NC at night at home. Currently on 5L via NC CRP 85.1 CT Chest No evidence of acute pulmonary embolism. Scattered new small foci of ground-glass airspace opacity throughout bilateral lungs, could suggest an atypical infectious process or inflammatory pneumonitis IV Decadron 10 mg, Mucinex, Albuteral PRN,  IS, Acapella Monitor on continouse pulse ox, check CRP Follows with Provenzano as an outpatient   8 mm pulmonary nodule in the right middle lobe lung base  Follow up as outpatient with Pulm   T2DM with hyperglycemia Lantis 10 units at bedtime , SSI and accucheck A1c   Chronic opiod depdnance Fibromyalgia Depression Resume suboxone Resume gapapentin, Baclofen and cymbalta  Resume linzess   HFpEF, Chronic PVD Resume home Plavix and statin
Onset of diarrhea and fever shortly after vaccine administration. Child has had diarrhea for 6 weeks--slowly improving.
People are dropping dead from heart attacks, strokes, cancer, with 2-3 feet long blood clots at 30 years old; People are dropping dead from heart attacks, strokes, cancer, with 2-3 feet long blood clots at 30 years old; People are dropping dead from heart attacks, strokes, cancer, with 2-3 feet long blood clots at 30 years old; People are dropping dead from heart attacks, strokes, cancer, with 2-3 feet long blood clots at 30 years old; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP) from medical information team.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: THROMBOSIS (death, medically significant), MYOCARDIAL INFARCTION (death, medically significant), CEREBROVASCULAR ACCIDENT (death, medically significant), NEOPLASM MALIGNANT (death, medically significant), outcome "fatal" and all described as "People are dropping dead from heart attacks, strokes, cancer, with 2-3 feet long blood clots at 30 years old". The patient date of death was unknown. Reported cause of death: "People are dropping dead from heart attacks, strokes, cancer, with 2-3 feet long blood clots at 30 years old". It was not reported if an autopsy was performed.  Clinical course: Reporter declines to provide demographic information. Reporter wants to know if graphene oxide is an ingredient of the Pfizer BioNTech COVID-19 vaccine. He insists that it is and that he has found in their lap more than 50% of the vials of the vaccine contain graphene oxide. Reporter questioning is Pfizer trying to kill everybody, are they not listing graphene oxide in their prescribing information, is your company trying to kill millions of people without them knowing, are lying about the ingredients. People are dropping dead from heart attacks, strokes, cancer, with 2-3 feet long blood clots at 30 years old etc. Reporter requests to speak to a manager.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the available information in the case, the causal association between the events thrombosis, myocardial infarction, cerebrovascular accident, neoplasm malignant and the suspect drug BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: People are dropping dead from heart attacks, strokes, cancer, with 2-3 feet long blood clots at 30 years old; People are dropping dead from heart attacks, strokes, cancer, with 2-3 feet long blood clots at 30 years old; People are dropping dead.
shingles; other zoster related injuries; This initial spontaneous report was received on from a lawyer regarding a case in litigation and refers to a currently 73 years old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant medication were not provided.   On or about 08-JAN-2010, the patient was vaccinated with a dose zoster vaccine live (ZOSTAVAX) (strength, dose, route of administration, lot # and expiration date were not reported) for the long-term prevention of shingles and zoster-related conditions.  Subsequently, on an unspecified date, Plaintiff was treated by healthcare provider in a healthcare facility for the following injuries resulting from Plaintiff's zoster vaccine live (ZOSTAVAX) use: shingles and other zoster-related injuries. The outcome of the events was unknown.   The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).
Sore arm x 2-3 days, itching arm started on 1/15 through 1/16, tingling lips for the first hour after vaccine, felt fatigued the day of the vaccine for about an hour after, On 1/14 at 0530 woke up with a horrible right calf cramp was relieved by massage. Sat at side of bed began feeling extremely nauseated, diaphoretic then syncopal episode that lasted approximately 5 seconds.
cold; pain; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), PAIN (pain), CHILLS (chills) and HEADACHE (headache) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     The patient's past medical history included Mitral valve replacement and Artificial cardiac pacemaker user. Concurrent medical conditions included Heart disease, unspecified since 2008. Concomitant products included APIXABAN (ELIQUIS) for Anticoagulant therapy, FUROSEMIDE for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced NASOPHARYNGITIS (cold), PAIN (pain), CHILLS (chills) and HEADACHE (headache). On 15-Feb-2021, NASOPHARYNGITIS (cold), PAIN (pain), CHILLS (chills) and HEADACHE (headache) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Patient's height was reported as 5'2. It was reported that the patient was very sensitive to vaccines, always had adverse reactions.  No treatment details were reported.   This case was linked to MOD-2022-563515, MOD-2022-563534, MOD-2022-563517, MOD-2022-563534 (Patient Link).
I experienced the following symptoms beginning approx. 12 hours after receiving the 2nd vaccination shot:   Fever of 100.6,  chills, nausea, body aches, and overall sluggishness. Symptoms were over within 24 hours.  Outcome included loss of 3 pounds!
Site: Pain at Injection Site-Mild, Systemic: Fever-Medium, Systemic: neck pain-Medium
had high fever up 107°F; shaking; breathing troubles. She could not take deep breath, had to breath thought her nose and release air though her mouth for 35 min; cough; fatigue; chilling; headache; muscle soreness; This is a spontaneous report from a contactable consumer (patient) via medical information team.  A 72-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: unknown), via an unspecified route of administration, on 04Mar2021 (at the age of 72 years old) as a dose 2, single for COVID-19 immunization. Patient medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: unknown) on 10Feb2021 (at the age of 72-year-old) as a dose 1, single for covid-19 immunization. On unspecified date on Friday in the middle of the night she had some breathing troubles. She could not take deep breath, had to breath thought her nose and release air though her mouth for 35 min. She was also chilling and shaking and had high fever up 107 degree F; when she started taking Advil and Tylenol the fever broke twice. Leaving that aside she had also fatigue, cough, muscle soreness, headache till this morning, no sore throat or congestion. She wanted to report this but wanted to be sure that since she got all the symptoms that everyone that had covid had, would she still be infectious. She thinks that the vaccine gave her covid 19. The outcome of the events was unknown. No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
9 cm wide by 7cm long circular area of redness and slight swelling, normal temperature as surrounding skin, bruise at site of injection (slightly above center of circle). No other symptoms. Already resolving. No anaphylaxis.
This spontaneous report as received from a 67 year old female patient refers to herself. The patient had no pertinent medical history, no drug reactions or allergies. On 29-SEP-2014 the patient was vaccinated with a dose of PNEUMOVAX 23, injection, 1 single shot (route and lot # unknown). Concomitant therapies included CRESTOR and lorazepam. On 29-SEP-2014, after receiving PNEUMOVAX 23, the patient experienced swelling and redness at the injection site. The patient could barely lift her arm. The patient sought medical attention and was treated with KEFLEX. There were no lab diagnostics studies performed. The outcome of events was reported as recovering/resolving at reporting time. The causality was not reported. Follow up information has been received from a physician on 30-OCT-2014 regarding a 67 year old female patient. There was no illness at time of vaccination, no pre-existing allergies, birth defects nor medical conditions, no adverse events following prior vaccination. On 29-SEP-2014 15:45 (reported as at 3:45 PM), the patient was vaccinated with a dose of PNEUMOVAX 23 lot # K009105, expiration date 21-JAN-2016, intramuscularly in the left deltoid. On an unknown date, the patient was vaccinated  with FLUVIRIN lot # 1412301, intramuscular, site reported as "Rt". On 30-SEP-2014 (previously reported as 29-SEP-2014), the patient experienced redness, pain and swelling of Lt (left) deltoid muscle at site of injection. The patient was treated with KEFLEX PO (per oral). On 10-OCT-2014, the patient recovered from the events. The adverse events were reported as serious, for the patient required medical intervention to prevent one of the outcome listed. Additional information is not expected, as all required information has been received.
23AUG92 tem 104.7 ax was brought down w/in 30 mins p/APAP & cool water bath; contacted MD about temp & rash noted on abdomen; was advised if temp remained up by 25AUG92 to bring pt to office for eval to r/o other problems;
COVID; This non-serious case was reported by a consumer via call center representative and described the occurrence of covid-19 in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced covid-19 (Verbatim: COVID). The outcome of the covid-19 was unknown.   It was unknown if the reporter considered the covid-19 to be related to Shingrix.     It was unknown if the company considered the covid-19 to be related to Shingrix.   Additional Information: GSK Receipt Date: 21-APR-2023 The adult patient reported the after the vaccination with Shingrix, experienced covid. It was not known that after which dose the patient experienced covid. Limited information provided.
The symptoms started 2 days after my second Covid 19 booster shot. I used to have non bothering very mild tinnitus on my left ear. But after second booster it became very bad and difficult.
Had an unexpected and unusual localized reaction to the PPD test. Symptoms included increased erythema, tenderness, and a nodule (26mm). It is suspected that a 0.1 ml of anthrax vaccine was erroneously administered to the sm instead of the standard PPD solution.
04/05/23 presents to ED for "shortness of breath". PMHx of "ESRD sp renal transplant (2018), HTN, T2DM"
dropped her coffee cup, so she thought she had torn her rotator cuff; rash on the vaccination arm with the size of an apple; tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ROTATOR CUFF SYNDROME (dropped her coffee cup, so she thought she had torn her rotator cuff), VACCINATION SITE RASH (rash on the vaccination arm with the size of an apple) and FATIGUE (tired) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No reported medical history.  Concomitant products included CHLOPHEDIANOL HCL, ATORVASTATIN, PROBIOTICS NOS, LISINOPRIL and METOPROLOL for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced FATIGUE (tired). On 08-Mar-2021, the patient experienced ROTATOR CUFF SYNDROME (dropped her coffee cup, so she thought she had torn her rotator cuff) and VACCINATION SITE RASH (rash on the vaccination arm with the size of an apple). On 07-Mar-2021, FATIGUE (tired) had resolved. At the time of the report, ROTATOR CUFF SYNDROME (dropped her coffee cup, so she thought she had torn her rotator cuff) and VACCINATION SITE RASH (rash on the vaccination arm with the size of an apple) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. Patient got the first dose of the vaccine on 4Mar2021. She was tired over the weekend. On 8Mar2021 she noticed a rash on the vaccination arm with the size of an apple. Also, she dropped her coffee cup, so she thought she had torn her rotator cuff. She went to the doctor and the PA send her to get an MRI.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow Up received on 06-MAY-2021 Contains Non Significant Information
02/28/23 presents to ED for "SOB, cough". PMHx of "HTN, HLP, AAA, bladder Ca, OA"
Information has been received from a medical assistant referring to multiple patients of unknown age and gender. No concurrent or historical conditions were reported. On unknown dates, the patients were vaccinated with improperly stored doses of (Oka/Merck) VARIVAX (lot# L004649, expiration date 11-FEB-2017; K021485, expiration date 03-NOV-2016; strength, dose and route unknown). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Decreased sensation to right side of face and upper back/chest, left lower leg within 30 minutes of vaccine. Next day sensation mostly decreased in face, some neck and leg.
Pain in the muscle and injection/muscle ache; Headache; Pain in the muscle and injection/muscle ache; Numbness; This spontaneous case was received on 30-Oct-2020 from pharmacist via Med Communications (reference number: SEQW20-04558) and concerned a 48-year-old, female patient.  The patient had no relevant medical history and was not taking any concomitant medications.  On 08-Oct-2020, the patient was vaccinated with Flucelvax QIV (influenza vaccine, subunit influenza virus vaccine polyvalent; dose: 0.5 ml, anatomical location: arm and route of administration: intramuscular) for influenza prophylaxis. The batch number reported was 276564. Expiry date reported was 30-JUN-2021. This was the first time the patient had ever received the vaccine.  On 09-Oct-2020, one day after vaccination, the patient felt pain in the muscle and injection site. The patient also had other typical side effects such as muscle ache and headache.  On an unspecified date in Oct-2020, reported as around that time, the numbness started, but the patient still felt numbness especially in the morning.  On an unspecified date in Oct-2020, the patient recovered from the event 'muscle ache', 'vaccination site pain' and headache. The reporter stated all these symptoms have gone away. Patient has no pain anymore.  At the time of initial reporting on 30-Oct-20220, the patient had not recovered from the event 'numbness'. The reporter stated, the numbness is not improving.  The reporter did not provide a causality assessment to Flucelvax QIV.  The reporter assessed the events as non-serious.  Company comment:The patient developed hypoaesthesia, myalgia, headache and vaccination site pain after vaccination with the suspect product, Flucelvax QIV. Chronology is plausible. The patient had no relevant medical history and was not taking any concomitant medications. Considering all above mentioned, causal relationship for all events is assessed as possibly related (defaults to ''related'' in the safety database for reporting purposes).; Sender's Comments: The patient developed hypoaesthesia, myalgia, headache and vaccination site pain after vaccination with the suspect product, Flucelvax QIV. Chronology is plausible. The patient had no relevant medical history and was not taking any concomitant medications. Considering all above mentioned, causal relationship for all events is assessed as possibly related (defaults to ''related'' in the safety database for reporting purposes).
Fever to 102 degrees F nausea, vomiting -> (severe) dizziness, rapid heartbeat, rash, aches/pain in legs, knees, ankles, weakness/ extreme fatigue.  Onset about 6-7 hours after inoculation, treated with TYLENOL, MOTRIN, Dr. prescribed ZOFRAN for nausea.  6 PM through the night.  Fever broke by 10 am following day
4 hours after vaccine, developed aching in joints and muscles which disappeared after 1 day.  15 days later,  woke up with all the same COVID-19 symptoms he was sufferering from a few months ago:  nausea, aching, feverish,  sweating, chills,  and brain fog.  Some shortness of breath.  Patient saw me a few days later feeling like he was dying.  He was treated with steroids and vitamin C along with glutathione IV treatment.  Started to feel better the next day.  A week later, felt nearly back to normal.